No Data
Percheron Warns Shareholders Over Unauthorized Proxy Forms; Shares Fall 17%
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Percheron Therapeutics Proposes to In-license New Drug Program for Rare Neurological Disease
Percheron Therapeutics Ltd: Letter From The Chair and Half Year Accounts
Percheron Therapeutics Expects Partnering Proposals This Month After Rapid Progress in Discussions | ASX:PER, OTC:PERCF
ASX Small-Cap Stocks to Watch